Anavex Life Sciences Corp (AVXL)

[ckent]

The biggest tell for me was the following:
"I want you to remember the numbers of the doses here for a reason... placebo declined... the medium dose stopped the decline... but the high dose group was above baseline... so patients coming into the trial came out with better cognitive features. And the reason I want you to remember these doses is that it's exactly the same doses as in the upcoming Alzheimer's study. Placebo, thirty, fifty."

Yes, really liked his "but not only that but we also..." emphasis.